These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3657888)

  • 1. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
    Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
    N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.
    Weiss NS; Ure CL; Ballard JH; Williams AR; Daling JR
    N Engl J Med; 1980 Nov; 303(21):1195-8. PubMed ID: 7421945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.
    Williams AR; Weiss NS; Ure CL; Ballard J; Daling JR
    Obstet Gynecol; 1982 Dec; 60(6):695-9. PubMed ID: 7145267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group.
    Cummings SR; Browner WS; Bauer D; Stone K; Ensrud K; Jamal S; Ettinger B
    N Engl J Med; 1998 Sep; 339(11):733-8. PubMed ID: 9731089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hip fracture in a Japanese cohort.
    Fujiwara S; Kasagi F; Yamada M; Kodama K
    J Bone Miner Res; 1997 Jul; 12(7):998-1004. PubMed ID: 9199997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
    Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
    Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Ensrud KE; Cauley J; Lipschutz R; Cummings SR
    Arch Intern Med; 1997 Apr; 157(8):857-63. PubMed ID: 9129545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastfeeding protects against hip fracture in postmenopausal women: the Tromsø study.
    Bjørnerem A; Ahmed LA; Jørgensen L; Størmer J; Joakimsen RM
    J Bone Miner Res; 2011 Dec; 26(12):2843-50. PubMed ID: 21898594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.
    Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I
    Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of postmenopausal estrogen therapy on bone density in elderly women.
    Felson DT; Zhang Y; Hannan MT; Kiel DP; Wilson PW; Anderson JJ
    N Engl J Med; 1993 Oct; 329(16):1141-6. PubMed ID: 8377776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study.
    Empana JP; Dargent-Molina P; Bréart G;
    J Am Geriatr Soc; 2004 May; 52(5):685-90. PubMed ID: 15086646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause and the risk of coronary heart disease in women.
    Colditz GA; Willett WC; Stampfer MJ; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1987 Apr; 316(18):1105-10. PubMed ID: 3574358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hip fractures. Epidemiology, risk factors, falls, energy absorption, hip protectors, and prevention.
    Lauritzen JB
    Dan Med Bull; 1997 Apr; 44(2):155-68. PubMed ID: 9151010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture prediction from bone mineral density in Japanese men and women.
    Fujiwara S; Kasagi F; Masunari N; Naito K; Suzuki G; Fukunaga M
    J Bone Miner Res; 2003 Aug; 18(8):1547-53. PubMed ID: 12929946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proximal femoral fractures: risk factors, bone mineral density, body composition and biochemical changes in and age-matched patients and controls].
    Vega EM; Mautalen CA; Carrilero P; Wittich A; Otaño Sahores A; Silberman FS
    Medicina (B Aires); 1996; 56(4):353-62. PubMed ID: 9138339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.